Timothy Eugene Sullivan - 10 Feb 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Financial Officer
Signature
/s/ David Watson as attorney-in-fact for Timothy Sullivan
Issuer symbol
APLS
Transactions as of
10 Feb 2022
Net transactions value
-$41,230
Form type
4
Filing time
14 Feb 2022, 15:17:39 UTC
Previous filing
01 Feb 2022
Next filing
17 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Tax liability $41,230 -875 -0.84% $47.12 103,403 10 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares used to cover tax withholding on a Restricted Stock Unit release.